Exchange: NASDAQ·Updated 07:30 PM EST
ONC logo

ONC BeOne Medicines Ltd - ADR

$390.94
$8.76
(2.19%)
Today
Closed $390.94
$0.00
(0.00%)
After Hours
Reported EarningsNov 5
Mkt Cap$41.16B
Vol356,973.00

About ONC

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
36

Bearish Sentiment

How do you feel about ONC?

StocktwitsEarnings
$ONC Q3 '26 Earnings Results & Recap BeOne Medicines expects operating cash flows and existing cash and cash equivalents to fund expenses and planned long-term investments for at least 12 months; approximately $258.8M of bank loans is due within 12 months.
abubnic
$ONC #ESMO BeOne Medicines' ESMO Congress 2026 data highlights a strong competitive edge over standard treatments, showcasing high response rates, strong durability, and clean safety profiles across three key oncology programs.

Advertisement|Remove ads.